Seoul Retina Investigator Group

Seoul Retina Investigator Group (SRIG) is a premier clinical research consortium and site management organization based in Seoul, South Korea, specializing in vitreoretinal diseases. The group integrates leading retinal specialists from South Korea's top academic medical centers, including Seoul National University and Asan Medical Center, to conduct high-quality multicenter clinical trials. SRIG serves as a critical partner for global pharmaceutical companies, providing the infrastructure for Phase 3 and Phase 4 studies, as well as investigator-initiated research in the East Asian population. Their work is particularly influential in the management of neovascular age-related macular degeneration and polypoidal choroidal vasculopathy. By utilizing standardized imaging protocols and a large patient network, SRIG contributes significant real-world evidence and clinical data to the global ophthalmic community.